» Articles » PMID: 22722403

BET Domain Co-regulators in Obesity, Inflammation and Cancer

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2012 Jun 23
PMID 22722403
Citations 364
Authors
Affiliations
Soon will be listed here.
Abstract

The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helices and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes. Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression. Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets. However, small molecules that inhibit bromodomain and extraterminal (BET) proteins have been described. We examine these developments and discuss the implications for small molecule epigenetic targeting of chromatin networks in cancer.

Citing Articles

Targeting FOXP1 phase separation in small cell lung cancer mechanisms of chemotherapy resistance.

Tang Y, Niu Y, Chen Y, Zhou X, Hu Y, Sun L Commun Biol. 2025; 8(1):431.

PMID: 40082538 PMC: 11906602. DOI: 10.1038/s42003-025-07804-7.


Advancements in PROTAC-based therapies for neurodegenerative diseases.

Kong D, Meng L, Lin P, Wu G Future Med Chem. 2025; 17(5):591-605.

PMID: 39931801 PMC: 11901405. DOI: 10.1080/17568919.2025.2463310.


Epigenetic Mechanisms in the Transcriptional Regulation of Circadian Rhythm in Mammals.

Mao W, Ge X, Chen Q, Li J Biology (Basel). 2025; 14(1.

PMID: 39857273 PMC: 11762092. DOI: 10.3390/biology14010042.


A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.

Wang L, Ke Y, He Q, Paerhati P, Zhuang W, Yue Y Theranostics. 2025; 15(4):1238-1254.

PMID: 39816690 PMC: 11729552. DOI: 10.7150/thno.102531.


BET inhibitor JQ1 induces apoptosis of ovarian and endometrial endometrioid carcinoma cells by downregulating .

Tanimoto S, Sone K, Jonouchi Y, Hachijo R, Suzuki E, Tsuboyama N Oncol Lett. 2024; 29(3):106.

PMID: 39736925 PMC: 11683525. DOI: 10.3892/ol.2024.14852.


References
1.
Kanno T, Kanno Y, Siegel R, Jang M, Lenardo M, Ozato K . Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol Cell. 2004; 13(1):33-43. DOI: 10.1016/s1097-2765(03)00482-9. View

2.
Wang E, Zou S, Tjian R . TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev. 1997; 11(20):2658-69. PMC: 316605. DOI: 10.1101/gad.11.20.2658. View

3.
Horn P, Peterson C . The bromodomain: a regulator of ATP-dependent chromatin remodeling?. Front Biosci. 2001; 6:D1019-23. DOI: 10.2741/horn. View

4.
Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K . The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A. 2003; 100(15):8758-63. PMC: 166386. DOI: 10.1073/pnas.1433065100. View

5.
French C, Ramirez C, Kolmakova J, Hickman T, Cameron M, Thyne M . BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2007; 27(15):2237-42. DOI: 10.1038/sj.onc.1210852. View